Interactions among microorganisms open up a new world for anti-infectious therapy

被引:6
|
作者
Zhang, Yejia [1 ]
Zhang, Hanchi [1 ,2 ]
Xu, Tian [1 ]
Zeng, Lingbing [1 ,2 ]
Liu, Fadi [3 ]
Huang, Xiaotian [1 ,4 ]
Liu, Qiong [1 ,4 ]
机构
[1] Nanchang Univ, Jiangxi Med Coll, Sch Med, Dept Med Microbiol, Nanchang, Peoples R China
[2] Nanchang Univ, Clin Med Coll 1, Nanchang, Peoples R China
[3] Childrens Hosp Jiangxi Prov, Dept Clin Lab, Nanchang, Peoples R China
[4] Nanchang Univ, Jiangxi Med Coll, Sch Med, Dept Med Microbiol, Nanchang 330006, Peoples R China
基金
中国国家自然科学基金;
关键词
bacteria; fungi; interaction; microbiota; virus; BIOSYNTHETIC GENE CLUSTERS; CANDIDA-ALBICANS; STREPTOCOCCUS-MUTANS; ATOPIC-DERMATITIS; BIOFILM FORMATION; NATURAL-PRODUCTS; VIRUS INCREASES; BACTERIAL; MICROBIOTA; INFLUENZA;
D O I
10.1111/febs.16705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human microbiome, containing bacteria, fungi, and viruses, is a community that coexists peacefully with humans most of the time, but with the potential to cause disease under certain conditions. When the environment changes or certain stimuli are received, microbes may interact with each other, causing or increasing the severity of disease in a host. With the appropriate methods, we can make these microbiota work for us, creating new applications for human health. This review discusses the wide range of interactions between microorganisms that result in an increase in susceptibility to, severity of, and mortality of diseases, and also briefly introduces how microorganisms interact with each other directly or indirectly. The study of microbial interactions and their mechanisms has revealed a new world of treatments for infectious disease. The regulation of the balance between intestinal flora, the correct application of probiotics, and the development of effective drugs by symbiosis all demonstrate the great contributions of the microbiota to human health and its powerful potential value. Consequently, the study of interactions between microorganisms plays an essential role in identifying the causes of diseases and the development of treatments.
引用
收藏
页码:1615 / 1631
页数:17
相关论文
共 50 条
  • [21] Impact of anti-infectious and corticosteroids on immunotherapy: Nivolumab and pembrozilumab follow-up in a French study.
    Metges, Jean-Philippe
    Michaud, Emmanuelle
    Lagadec, Delphine Deniel
    Marhuenda, Fanny
    Chaslerie, Anicet
    Grude, Francoise
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] NEW MATOR ANTI-INFECTIOUS CHEMOTHERAPY ASSOCIATION SULFAMETHOXAZOLE TRIMETHO PRIME (BACTERIOLOGY AND CLINICAL STUDY)
    LAFAIX, C
    CAMERLYNCK, P
    DIOP, I
    GUERIN, M
    REY, M
    PRESSE MEDICALE, 1970, 78 (30): : 1375 - +
  • [23] New research on the preventative anti-infectious resistance conferred by the injections of protein - Is it modified by the poison at vagosympathetic action?
    Arloing, F
    Langeron, L
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1923, 88 : 1295 - 1297
  • [24] New Microbicidal Functions of Tracheal Glands: Defective Anti-Infectious Response to Pseudomonas aeruginosa in Cystic Fibrosis
    Bastonero, Sonia
    Le Priol, Yannick
    Armand, Martine
    Bernard, Christophe S.
    Reynaud-Gaubert, Martine
    Olive, Daniel
    Parzy, Daniel
    de Bentzmann, Sophie
    Capo, Christian
    Mege, Jean-Louis
    PLOS ONE, 2009, 4 (04):
  • [25] Recent Advance in Research of New Anti-Infectious Agents-Discovery Chemical Biology and Development Foreword
    Tomoda, Hiroshi
    Sekimizu, Kazuhisa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (01): : 35 - 36
  • [26] Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations
    Sanchez-Ramon, Silvia
    Conejero, Laura
    Netea, Mihai G.
    Sancho, David
    Palomares, Oscar
    Luis Subiza, Jose
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [28] TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents
    Juspin, Thierry
    Laget, Michele
    Terme, Thierry
    Azas, Nadine
    Vanelle, Patrice
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) : 840 - 845
  • [29] Benefit of anti-infectious prophylaxis in patients with acute myeloid leukemia or high-risk myelodysplastic syndrome receiving frontline "Targeted Therapy"
    Jain, Nitin
    Mattiuzzi, Gloria N.
    Cortes, Jorge
    Cassat, Jennifer
    Garcia-Manero, Guillermo
    Ravandi-Kashani, Farhad
    Pierce, Sherry
    Borthakur, Gautam
    O'Brien, Susan
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 841A - 841A
  • [30] Management of infections due to the Varicella-Zoster virus - 11th Consensus Conference on Anti-Infectious Therapy of the French-Speaking Society of Infectious Diseases (SPILF)
    Peyramond, D
    Chidiac, C
    Lucht, F
    Perronne, C
    Saimot, AG
    Soussy, JC
    Stahl, JP
    Decazes, JM
    EUROPEAN JOURNAL OF DERMATOLOGY, 1998, 8 (06) : 397 - 402